Trial
NCT00837200
Oncaspar/Doxil/Decadron in Patients With Refractory Lymphoid Malignancies
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Milton S. Hershey Medical Center
Collaborators
—
Condition
Non-hodgkins Lymphoma
Intervention
Oncaspar, Doxil, Decadron
Why stopped
PI said to close accrual do to funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-07-24